Fresenius Kabi Issues Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-Up

RegulatoryMorphine Sulfate Injection, USP Simplist®Negative

AI Analysis

Summary

Fresenius Kabi voluntarily recalled one lot of Morphine Sulfate Injection USP (Simplist® 2 mg/1 mL) due to a labeling mix-up. The recall was announced on August 4, 2026.

Outcome Details

Voluntary recall of one lot due to labeling mix-up

Importance:3/10

Sentiment:

-0.60

recallproduct_safetylabeling_errormorphineinjection

Related Companies

$FMCQF

Read the original article

Published by Drugs.com FDA MedWatch Alerts on August 5, 2026 3:28 PM

Read Original